Related Experiment Videos
Transforming growth factor-beta expression in macrophages during hypercholesterolemic states
1Department of Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania.
The American Journal of Physiology
|December 1, 1994
Summary
Glomerular macrophages are a source of transforming growth factor-beta 1 (TGF-β1) in nephrotic rats, contributing to glomerulosclerosis. This study identifies macrophages as key players in kidney disease progression.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Macrophage infiltration is common in glomerulopathies.
- Macrophages may drive glomerulosclerosis by increasing matrix accumulation via TGF-β.
- The cellular source of elevated glomerular TGF-β1 in nephrosis is unknown.
Purpose of the Study:
- To determine if glomerular macrophages are the source of increased transforming growth factor-beta 1 (TGF-β1) in a rat model of glomerulopathy.
- To investigate the expression of TGF-β isoforms in macrophages during nephrosis and hypercholesterolemia.
Main Methods:
- Polymerase chain reaction (PCR) and Northern analysis were used.
- Glomerular and peritoneal macrophages were isolated from rats with puromycin aminonucleoside (PA) nephrosis or dietary hypercholesterolemia.
- TGF-β1, TGF-β2, and TGF-β3 mRNA expression was analyzed.
Main Results:
- Glomerular macrophages from nephrotic and hypercholesterolemic rats expressed TGF-β1 mRNA.
- Peritoneal macrophages also showed increased TGF-β1 mRNA in these conditions.
- TGF-β2 mRNA was detected in glomeruli but not in isolated macrophages; TGF-β3 was only found in cell lines.
Conclusions:
- Glomerular macrophages are a cellular source of enhanced TGF-β1 during the acute nephrotic phase and hypercholesterolemia.
- This finding implicates macrophages in the progression of glomerulopathy and glomerulosclerosis.
- Targeting macrophage-derived TGF-β1 may offer therapeutic potential for kidney diseases.